Global Sodium Hyaluronate Intra-Articular Injection Market Growth 2025-2031

The global Sodium Hyaluronate Intra-Articular Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Sodium Hyaluronate Intra-Articular Injection refers to an injection whose main active ingredient is sodium hyaluronate, which is injected into the joint cavity after puncture of the joint cavity. Sodium hyaluronate injection appears as a colorless, clear and viscous aqueous injection with no odor. It can lubricate the joint cavity and relieve knee joint pain. It can be used to treat orthopedic diseases such as osteoarthritis. Sodium Hyaluronate Intra-Articular Injection is widely used in the field of orthopedic treatment, and its indications include periarthritis of the shoulder, osteoarthritis of the knee, etc.

United States market for Sodium Hyaluronate Intra-Articular Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Sodium Hyaluronate Intra-Articular Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Sodium Hyaluronate Intra-Articular Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Sodium Hyaluronate Intra-Articular Injection players cover Seikagaku, Bioventus, Ferring Pharmaceuticals, Sanofi, Anika Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Sodium Hyaluronate Intra-Articular Injection Industry Forecast” looks at past sales and reviews total world Sodium Hyaluronate Intra-Articular Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Sodium Hyaluronate Intra-Articular Injection sales for 2025 through 2031. With Sodium Hyaluronate Intra-Articular Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Hyaluronate Intra-Articular Injection industry.

This Insight Report provides a comprehensive analysis of the global Sodium Hyaluronate Intra-Articular Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Hyaluronate Intra-Articular Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Hyaluronate Intra-Articular Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Hyaluronate Intra-Articular Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Hyaluronate Intra-Articular Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Hyaluronate Intra-Articular Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
High Molecular Weight
Low Molecular Weight

Segmentation by Application:
Hospitals
Clinics
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Seikagaku
Bioventus
Ferring Pharmaceuticals
Sanofi
Anika Therapeutics
LG Chem
Zimmer Biomet
Contipro
Altergon
Nichi-Iko Pharmaceutical
Hymovis
OrthogenRx
Fidia Pharma
SciVision Biotech
Arthrex
Aetos Pharma
Incepta Pharmaceuticals
HHT Pharma
Meiji Seika Pharma
Bloomage Biotech
Haohai Biological Technology
Shanghai Jingfeng Pharmaceutical
Shandong Topscience Biotech
Hang Zhou Singclean Medical Products

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sodium Hyaluronate Intra-Articular Injection market?

What factors are driving Sodium Hyaluronate Intra-Articular Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sodium Hyaluronate Intra-Articular Injection market opportunities vary by end market size?

How does Sodium Hyaluronate Intra-Articular Injection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more